Utama › Kanser Payudara › Texas › Fort Worth
Kajian klinikal Kanser Payudara di Fort Worth, TX
11 kajian untuk Kanser Payudara sedang mencari peserta di lokasi dalam dan sekitar Fort Worth (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
IKS014 in Advanced Solid Tumors That Express HER2
Mengambil pesertaFasa 1
- START Dallas - Fort Worth, Fort Worth
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Mengambil pesertaFasa 3
- JPS Health Network ( Site 0067), Fort Worth
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Mengambil pesertaFasa 3
- JPS Oncology and Infusion Center ( Site 0083), Fort Worth
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Mengambil pesertaFasa 3
- The Center for Cancer and Blood Disorders ( Site 0041), Fort Worth
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Mengambil pesertaFasa 3
- JPS Health Network, Fort Worth
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Mengambil pesertaFasa 3
- JPS Health Network - Trinity Springs Pavilion, Fort Worth
- OneR The Center For Cancer And Blood Disorders (Texas Cancer Care), Fort Worth
- UT Southwestern Moncrief Cancer Institute, Fort Worth
- dan 2 lagi
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Mengambil pesertaFasa 1
- Start - Dfw, Fort Worth
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Mengambil pesertaFasa 3
- Research Site, Fort Worth
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Mengambil pesertaFasa 3
- JPS Health Network, Fort Worth
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Mengambil pesertaFasa 1/2
- USOR Texas Oncology, Fort Worth
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Mengambil pesertaFasa 3
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
Kajian Kanser Payudara di bandar lain
- New York City, NY134 kajian
- Houston, TX126 kajian
- Boston, MA111 kajian
- Nashville, TN80 kajian
- Los Angeles, CA72 kajian
- Edison, NJ68 kajian
- St. Louis, MO64 kajian
- Durham, NC63 kajian
- Queens, NY63 kajian
- Chicago, IL58 kajian
- Philadelphia, PA56 kajian
- Dallas, TX55 kajian
Kajian lain di Fort Worth
- Kanser Paru-paru Bukan Sel Kecil18 kajian
- Kanser Ovari17 kajian
- Kanser Endometrium12 kajian
- Kanser (semua jenis)9 kajian
- Kanser Prostat9 kajian
- Kegagalan Jantung7 kajian
- Kanser Kolorektal7 kajian
- Kanser Payudara Triple-Negatif7 kajian
- Kanser Metastatik7 kajian
- Kanser Ginjal (Karsinoma Sel Renal)7 kajian
- Kolitis Ulseratif7 kajian
- Degenerasi Makula7 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.